Cervical discectomy, fusion is durable and cost-effective

March 29, 2013
Cervical discectomy, fusion is durable and cost-effective
Single-level instrumented anterior cervical discectomy and fusion is durable and cost-effective after five years of follow-up, according to a study published in the March 15 issue of Spine.

(HealthDay)—Single-level instrumented anterior cervical discectomy and fusion (ACDF) is durable and cost-effective after five years of follow-up, according to a study published in the March 15 issue of Spine.

Leah Y. Carreon, M.D., from the Norton Leatherman Spine Center in Louisville, Ky., and colleagues analyzed data from 352 control patients (182 women and 170 men; mean age, 44.6 years) who had undergone ACDF with complete five-year follow-up data and were part of a trial for arthroplasty. Using the 2012 Fee schedule, direct costs of the interventions were determined. Short Form-6D was used to determine health utility.

The researchers found that cost per patient for the index ACDF was $15,714. During five years of follow-up, 41 repeat ACDFs, 15 posterior fusions, six foraminotomies, two implant removals, two , and one esophageal fistula repair were performed. In each year of follow-up, mean quality-adjusted life year (QALY) gained was 0.16, 0.18, 0.17, 0.18, and 0.18, with a cumulative 0.88 QALY gain over five years. At one year, the cost/QALY gain was $104,831; $53,074 at year two; $37,717 at year three; $28,383 at year four; and $23,460 at year five. Subanalysis included upper extremity procedures performed (11 nerve releases and 26 rotator cuff repairs were done within five years after the index ACDF). Including upper extremity procedures, the cost/QALY gain at one year was $106,256; $54,622 at year two; $38,836 at year three; $29,454 at year four; and $24,479 at year five.

"This study indicates that at five-year follow-up, single-level instrumented ACDF is both effective and durable resulting in a favorable cost/QALY gained as compared to other widely accepted ," the authors write.

Explore further: Cell saver not cost-effective in single-level lumbar surgery

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Cell saver not cost-effective in single-level lumbar surgery

October 15, 2012

(HealthDay)—Use of intraoperative blood salvage (cell saver) is not cost-effective for adult patients undergoing single-level posterior lumbar decompression and fusion (PLDF) surgery, according to research published online ...

Dysphagia not tied to post-anterior cervical op swelling

October 7, 2012

(HealthDay)—Although significant soft-tissue swelling can occur after anterior cervical discectomy and fusion (ACDF) procedures, the width of the prevertebral soft-tissue swelling on radiographic analysis does not correlate ...

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.